A detailed history of Engineers Gate Manager LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 29,875 shares of BHC stock, worth $230,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,875
Previous 188,165 84.12%
Holding current value
$230,635
Previous $1.31 Million 81.46%
% of portfolio
0.0%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.22 - $8.26 $826,273 - $1.31 Million
-158,290 Reduced 84.12%
29,875 $243,000
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $502,810 - $858,075
82,428 Added 77.96%
188,165 $1.31 Million
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $821,576 - $1.12 Million
105,737 New
105,737 $1.12 Million
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $297,618 - $387,539
48,870 New
48,870 $306,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $101,247 - $338,877
14,341 Added 27.9%
65,734 $550,000
Q1 2022

May 16, 2022

BUY
$21.6 - $27.79 $715,284 - $920,265
33,115 Added 181.17%
51,393 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $420,394 - $530,244
18,278 New
18,278 $505,000
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $281,514 - $335,600
-10,263 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $354,827 - $570,845
-16,604 Reduced 61.8%
10,263 $326,000
Q4 2020

Feb 16, 2021

BUY
$15.31 - $21.12 $27,052 - $37,319
1,767 Added 7.04%
26,867 $559,000
Q3 2020

Nov 16, 2020

BUY
$14.88 - $20.13 $373,488 - $505,263
25,100 New
25,100 $390,000
Q2 2020

Aug 17, 2020

SELL
$13.31 - $20.51 $509,866 - $785,676
-38,307 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $280,199 - $653,006
21,587 Added 129.11%
38,307 $594,000
Q4 2019

Feb 14, 2020

BUY
$18.89 - $31.89 $315,840 - $533,200
16,720 New
16,720 $500,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.79B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.